SCHEMBL32688249

SCHEMBL32688249

COC(=O)c1ccc(-c2ccc(-c3c(C#N)c(SCc4nnn[nH]4)[nH]c(=O)c3C#N)cc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ ADORA1 P30542 4/20 0.36
▸ ADORA2B P29275 2/20 0.36
▸ ALDH1A1 P00352 3/20 0.35
▸ ACMSD Q8TDX5 3/20 0.35
▸ ADORA2A P29274 3/20 0.34
▸ HSD11B1 P28845 2/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ GRK6 P43250 1/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ ADORA3 P0DMS8 1/20 0.33
▸ TP53 P04637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32688180 0.89 POLB (0.49) MEN1POLBKMT2AADORA1ADORA2B
SCHEMBL32688296 0.87 ACMSD (0.35) ACMSDHSD11B1PDE9A
SCHEMBL32687990 0.87 ADORA1 (0.44) MEN1KMT2AADORA1ADORA2BALDH1A1
SCHEMBL32688034 0.86 PDE9A (0.43) MEN1POLBKMT2AADORA1MAPK1
SCHEMBL32688075 0.85 ADORA3 (0.46) MEN1POLBKMT2AADORA1ADORA2B
SCHEMBL32688166 0.85 HSD11B1 (0.41) MEN1KMT2AADORA1ADORA2BHSD11B1
SCHEMBL32688269 0.85 HSD11B1 (0.45) MEN1POLBKMT2AALDH1A1ACMSD
SCHEMBL32688008 0.85 MEN1 (0.42) MEN1POLBKMT2AADORA1ADORA2B
SCHEMBL32688160 0.84 HSD11B1 (0.36) ADORA1ADORA2BADORA2AHSD11B1ADORA3
SCHEMBL32688201 0.83 HSD11B1 (0.36) HSD11B1PDE9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors ORSOBIO INC (US) 2026-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors CPT1B, CBR1, MUSK MEN1 4353/4885POLB 508/4885KMT2A 3400/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback